Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study
    Chen, Jason C.
    Subramanian, Lalita
    Skolarus, Ted A.
    Hawley, Sarah T.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Borza, Tudor
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025, : 1107 - 1115
  • [22] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [23] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
  • [24] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979
  • [25] Dutasteride and active surveillance of low-risk prostate cancer
    Fleshner, Neil E.
    LANCET, 2012, 379 (9826): : 1590 - 1590
  • [26] Active surveillance for low-risk prostate cancer: an update
    Lawrentschuk, Nathan
    Klotz, Laurence
    NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
  • [27] Active surveillance for low-risk prostate cancer: an update
    Nathan Lawrentschuk
    Laurence Klotz
    Nature Reviews Urology, 2011, 8 : 312 - 320
  • [28] Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer
    Davison, B. Joyce
    Goldenberg, S. Larry
    BJU INTERNATIONAL, 2011, 108 (11) : 1787 - 1793
  • [29] Active Surveillance in Low-Risk Prostate Cancer. Patient Acceptance and Results
    Hernandez, V.
    Blazquez, C.
    de la Pena, E.
    Perez-Fernandez, E.
    Diaz, F. J.
    Llorente, C.
    ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (09): : 533 - 537
  • [30] Active surveillance for men with low-risk prostate cancer
    Sturch, Paul
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 14 - 16